MOH: Two people suffered acute poisoning after taking Ivermectin

The Ministry of Health has reported two individuals had suffered acute poisoning after taking Ivermectin. The anti-parasitic drug has been widely speculated as the miracle drug to treat COVID-19 but it has not yet received approval from Malaysian health authorities for human consumption.

The first acute poisoning case was a 35-year-old individual who has suffered breathing difficulties that lasted five days after consuming one Ivermectin pill. The other case was a senior citizen that was found unconscious after consuming 15 Ivermectin pills in one go. Both cases have been reported to the National Poison Centre.

The Ministry stressed that Ivermectin is still not approved for treatment or prevention of COVID-19. It is aware of the illegal sale of the drug in the market. The Ministry has also warned the public that consuming Ivermectin at incorrect dosages can cause poisoning.

Minor side effects of taking Ivermectin include nausea, giddiness, diarrhea and stomach discomfort. The severe side effects can cause low blood pressure, lung damage and even death. The Ministry added that there is currently no antidote or specific treatment for Ivermectin poisoning in humans.

Ministry of Health has not completely ruled out the possibility of using Ivermectin and is running trials to evaluate its efficacy and safety in high-risk COVID-19 patients. Health Director-General Dr Noor Hisham shared that clinical trials are still ongoing but have been inconclusive so far.

He said that Ivermectin experiments in test tubes (in vitro) have shown some positive results but tests on living organisms (in vivo) have not. High doses are needed to have an antiviral effect which can present grave dangers and complications to patients.

The Health Ministry is currently testing three new drugs for COVID-19 treatment and the results are expected to be released next month.

The National Pharmaceutical Regulatory Agency (NPRA) has not approved any products with Ivermectin as an active ingredient to be used for human consumption. Ivermectin is commonly used for animals to prevent heartworm and there is a specific dosage based on the weight or size of the animal.

Besides Malaysia, the US FDA has also advised against the use of Ivermectin and they released an article titled “Why You Should Not Use Ivermectin to Treat or Prevent COVID-19“. The European Medicines Agency (EMA) has also issued a similar warning against the use of Ivermectin to treat COVID-19 cases.

At the moment, there is little scientific data to support the use of Ivermectin in treating COVID-19 cases. The Journal of American Medical Association (JAMA) has published a randomised-control trial involving 476 adults. After 5 days of taking Ivermectin, the results show no significant improvement in COVID-19 symptoms.

[ SOURCE 2, IMAGE SOURCE ]

Recent Posts

BMW iX1 eDrive20L M Sport: The first BMW EV with long-wheelbase in Malaysia, priced at RM255k est

Revealed alongside the CKD version of the BMW i5 eDrive 40 M Sport Pro, the…

43 minutes ago

Nissan Finally Gives the Serena a Real Hybrid Powertrain in Malaysia. Estimated from RM160k to RM180k

The sixth-generation Nissan Serena is gearing up for its Malaysian debut in March 2026, bringing…

2 hours ago

Tesla Model Y 2026 for Malaysia gets a larger 16-inch screen and black headliner

The updated 2026 Tesla Model Y, featuring a larger screen and refreshed interior, is now…

3 hours ago

Malaysia to review minimum user threshold for mandatory social media licensing after X’s Grok issue

Malaysia’s Ministry of Communications is reviewing the current user threshold for mandatory social media licensing…

5 hours ago

BMW i5 eDrive40 M Sport Pro CKD is here: Assembled in Kulim with more range and lower price

BMW Malaysia has unveiled the locally assembled (CKD) version of the BMW i5 eDrive40 electric…

23 hours ago

TNB Electron deploys 240kW DC Charger in Kuala Terengganu, free charging for limited time

TNB Electron continues with its EV charging network expansion and their latest deployment is in…

23 hours ago

This website uses cookies.